The source of choice for concise and easy-to-use guidance on the latest advances in therapeutics. More than 300 leading practitioners from 15 countries around the world describe their preferred techniques for managing hundreds of common disorders affecting every organ system. With 97% new authorship, each chapter is fresh and presented differently than in previous editions.Olanzapine (Zyprexa) Data on the efficacy of olanzapine in treatment- refractory schizophrenia are more mixed. ... In summary, these studies do not suggest that olanzapine is robustly efficacious in a severely refractory population of patients.
|Author||:||Robert E. Rakel, Edward T. Bope|
|Publisher||:||W B Saunders Company - 2002-01-01|